1. Saino Medical: the loss of 81.5422 million yuan is expected to change from profit to loss in the first half of the year
Saino Medical announced that it expects a loss of 81.5422 million yuan in the first half and a net profit of 31.36 million yuan in the same period last year. The first generation of coronary stent products sold by the company were not included in the national collection of coronary stents, resulting in a sharp drop of 85.61% in sales of coronary stent products in the first half of the year compared with the same period last year.
two。 KuaiBao's performance of Weixing shares: the first-half net profit of 237 million yuan fell 4.3% compared with the same period last year.
Weixing shares released its half-year performance KuaiBao in 2021, with total operating income of 1.483 billion yuan, an increase of 31.40% over the same period last year. Net profit belonging to shareholders of listed companies was 237 million yuan, down 4.30% from the same period last year. Basic earnings per share is 0.3 yuan.
3. Huichen shares: Hunan Wenlu, a shareholder, intends to reduce its holdings by no more than 2.69%.
Huichen shares announced that Hunan Wenlu, a 5.05% shareholder, intends to reduce its holdings by no more than 2.69%.
4. Cosco Haineng: it is expected that the net profit in the first half of the year will decline by 80.57% compared with the same period last year
Cosco Haineng announced that it is expected to make a net profit of 465 million yuan to 565 million yuan in the first half, down 80.57% and 84.01% compared with the same period last year. In the first half of the year, the recovery of global oil demand was slow, and the continuous implementation of the OPEC+ production reduction agreement promoted the destocking of oil. The situation of oversupply led to the continued weakness of the international oil transportation market. Coupled with the increase in international fuel prices compared with the same period last year, the revenue level of the international oil transportation market continued to hover at an all-time low.
5. Huaxi Biology: the 1% share reduction plan of shareholders Ying Rui Wuyuan has been completed.
Huaxi biological announcement, June 29-July 16, shareholders Yingrui Wuyuan through a centralized bidding transaction to reduce the company's shares of 4.8 million shares, accounting for 1% of the company's total shares, the reduction price range of 264.366-314.278 yuan per share, the reduction plan has been completed.
6. Jingneng Electric Power: estimated loss of 300 million yuan in the first half of the year
Jingneng Electric Power announced that it is expected to lose 300 million yuan in the first half of the year, with a net profit of 837 million yuan in the same period last year.